|4.||Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome)
|1.||Pece, Alfredo: 4 articles (06/2010 - 10/2004)|
|2.||Introini, Ugo: 3 articles (02/2014 - 10/2004)|
|3.||Holz, Frank G: 3 articles (07/2013 - 07/2011)|
|4.||Charbel Issa, Peter: 3 articles (07/2013 - 07/2011)|
|5.||Finger, Robert P: 3 articles (07/2013 - 07/2011)|
|6.||Yoshimura, Nagahisa: 3 articles (04/2013 - 05/2010)|
|7.||Georgalas, Ilias: 3 articles (03/2011 - 02/2009)|
|8.||Bonomo, Pedro Paulo: 3 articles (09/2010 - 12/2006)|
|9.||Klancnik, James M: 3 articles (05/2010 - 09/2007)|
|10.||Freund, K Bailey: 3 articles (05/2010 - 09/2007)|
09/01/2010 - "Intravitreal bevacizumab appears to be effective in stabilizing and recovering visual acuity in eyes with CNV associated with angioid streaks. "
11/01/2011 - "The 1-year outcomes suggest intravitreal bevacizumab to be a promising treatment for CNV associated with angioid streaks, resulting in both functional and anatomical improvements. "
02/01/2009 - "To evaluate the efficacy of intravitreal bevacizumab (IB) in the long-term control of subfoveal choroidal neovascularisation (CNV) associated with angioid streaks (AS). "
01/01/2009 - "To evaluate the safety and efficacy of intravitreal bevacizumab (Avastin) as treatment for choroidal neovascularisation (CNV) associated with angioid streaks A non-randomised, interventional case series conducted on eyes with subfoveal CNV associated with angioid streaks. "
10/01/2015 - "Intravitreal bevacizumab stabilized vision in eyes with CNV and angioid streaks. "
|2.||ranibizumab (Lucentis)FDA Link
11/01/2010 - "Ranibizumab seems to be a safe therapeutic option in CNV associated with angioid streaks."
05/01/2014 - "The use of intravitreal ranibizumab for the treatment of CNV in patients with angioid streaks has shown favorable results. "
01/01/2014 - "Intravitreal ranibizumab for bilateral choroidal neovascularisation in a patient with angioid streaks."
09/01/2012 - "To assess the medium to long-term efficacy and safety of intravitreal ranibizumab for the treatment of choroidal neovascularisation (CNV) secondary to angioid streaks (AS). "
09/01/2012 - "Intravitreal ranibizumab for the treatment of choroidal neovascularisation secondary to angioid streaks."
|3.||verteporfin (Visudyne)FDA Link
09/01/2002 - "Further studies with longer follow up are necessary to confirm whether verteporfin therapy is beneficial for subfoveal choroidal neovascularization related to angioid streaks."
01/01/2003 - "Verteporfin for choroidal neovascularization-associated with angioid streaks does not appear to significantly alter the course of this disease with most eyes undergoing enlargement and disciform transformation of the neovascular process. "
01/01/2003 - "To evaluate the efficacy of photodynamic therapy with verteporfin in the management of choroidal neovascularization (CNV) associated with angioid streaks. "
09/01/2002 - "To evaluate safety and efficacy of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization associated with angioid streaks. "
09/01/2007 - "Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks."
09/01/2007 - "PDT for CNV associated with angioid streaks seemed to slow down but not prevent the progression of the disease and associated visual loss."
12/01/2006 - "In general, PDT of CNV is less favourable in angioid streaks than in AMD. "
12/01/2006 - "We reviewed 4 eyes with subfoveal and 1 eye with juxtafoveal CNV in angioid streaks of 5 patients (4 male, 1 female) treated by PDT between 2000 and 2005. "
12/01/2006 - "We present the functional and anatomic outcome of 5 patients with CNV due to angioid streaks treated by PDT. "
11/01/2005 - "PDT for CNV associated with angioid streaks seemed to slow down but not prevent the progression of the disease and associated visual loss. "
|5.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/01/2013 - "Intravitreal vascular endothelial growth factor inhibitors are currently the most effective treatment of CNV due to angioid streaks."
04/01/2010 - "[Treatment of angioid streaks with anti-VEGF]."
01/01/2010 - "Overall, based on the evidence available, intravitreal treatment with anti-VEGF seems to be the best choice at present to treat patients with CNV secondary to angioid streaks and PXE."
01/01/2013 - "This case illustrates the efficacy of intravitreal anti-VEGF therapy for choroidal neovascularization in angioid streaks. "
06/01/2012 - "Eyes with angioid streaks were classified into 1 of 4 groups: those without choroidal neovascularization (CNV) (Group 2); those with CNV that had no history of treatment (Group 3); those with CNV that had previously received only anti-vascular endothelial growth factor treatments (Group 4); and those with CNV that had previously received photodynamic therapy (Group 5). "
|6.||Endothelial Growth FactorsIBA
05/01/2010 - "The purpose of this study was to report long-term results of intravitreal antivascular endothelial growth factor therapy in the management of choroidal neovascularization in patients with angioid streaks associated with pseudoxanthoma elasticum. "
01/01/2010 - "From the present evidence it may be concluded that intravitreal antivascular endothelial growth factor (anti-VEGF) therapy with ranibizumab or bevacizumaab is beneficial for the treatment of CNV secondary to angioid streaks associated with PXE. "
|7.||Fluorescein (Funduscein)FDA LinkGeneric
07/01/2015 - "Fundoscopy and fluorescein angiography showed angioid streaks encircling the optic discs of both eyes (OU). "
08/01/2012 - "We reviewed colour fundus photographs, fluorescein angiograms, and SD-OCT images of 52 eyes (27 Japanese patients) with angioid streaks (AS) due to PXE. "
05/01/1998 - "Indocyanine angiography outlines angioid streaks as well as the peau d'orange appearance better than fluorescein angiography in the majority of cases. "
04/01/1996 - "Beside the finding of angioid streaks fluorescein angiography more precisely demonstrates extent of Bruch membrane abnormalities and alteration of pigmentary epithelium of the retina. "
04/01/1996 - "[Fluorescein angiography of angioid streaks]."
|8.||Indocyanine Green (Cardio-Green)FDA LinkGeneric
05/01/2001 - "The indocyanine green angiography allows for the early detection of angioid streaks and diagnosis in young patients."
05/01/2001 - "The indocyanine green angiography contributes to the diagnosis of angioid streaks. "
05/01/2001 - "The angioid streaks were more clearly visualized by indocyanine green angiography. "
05/01/2001 - "[Indocyanine green angiography in angioid streaks]."
03/01/2001 - "Indocyanine green angiography is an adjunctive diagnostic tool in the detection of subretinal neovascular membranes in angioid streaks. "
07/01/2008 - "The study included 39 eyes of 36 patients with subfoveal CNV secondary to multifocal choroiditis (n = 12), angioid streaks (n = 11), myopic degeneration (n = 10), idiopathic disease (n = 4), or other disease (n = 2). "
01/01/1995 - "17 eyes (16 patients) were identified in which subfoveal neovascularization was caused by myopic degeneration (5 eyes), angioid streaks (5 eyes of 4 patients), idiopathic neovascularization (4 eyes), punctate inner choroidopathy (1 eye), multifocal choroiditis (1 eye), or candida chorioretinitis (1 eye). "
01/01/1998 - "A retrospective study was carried out of 31 consecutive patients undergoing vitrectomy, parafoveal retinotomy and removal of subfoveal choroidal neovascular membranes that were either idiopathic or associated with multifocal choroiditis, high myopia, trauma or angioid streaks. "
01/01/2001 - "Our initial experience with limited macular translocation shows that this treatment modality offers the potential to improve visual function in some eyes with subfoveal choroidal neovascularization secondary to myopia, ocular histoplasmosis syndrome, angioid streaks, idiopathic neovascularization, and multifocal choroiditis. "
01/01/2001 - "We conducted a retrospective study of 23 eyes of 22 patients with choroidal neovascularization involving the foveal center secondary to pathologic myopia (11 eyes), ocular histoplasmosis syndrome (four eyes), angioid streaks (four eyes), idiopathic neovascularization (three eyes), and multifocal choroiditis (one eye), in which the fovea was moved inferiorly by means of limited macular translocation surgery. "
01/01/2007 - "The iron deposition may predispose to angioid streaks. "
04/01/1988 - "The occurrence of angioid streaks in a patient with a relatively normal iron balance and only very mild haemolysis may be explained by the combination of pregnancy with associated multiple transfusions in a myopic patient where an inherent defect in Bruch's membrane may exist."
01/01/1987 - "These studies suggest that calcification rather than iron deposition is the major factor leading to brittleness of Bruch's membrane in patients with hemolytic anemia and angioid streaks."
04/01/1993 - "The pathogenesis of angioid streaks in the hemoglobinopathies is thought to be linked to iron deposition in Bruch's membrane. "
|1.||Photochemotherapy (Photodynamic Therapy)
01/01/2009 - "Angioid streaks - clinical course and photodynamic therapy. "
12/01/2007 - "[Photodynamic therapy in angioid streaks]."
08/01/2007 - "Photodynamic therapy for angioid streaks."
12/01/2006 - "[Photodynamic therapy in classic chorioidal neovascularisation in patients with angioid streaks]."
12/01/2007 - "Photodynamic therapy in choroidal neovascularization related to angioid streaks does not appear to alter the course of this disease, but it does slow its progression."
05/01/2014 - "A 28 year old woman with angioid streaks and SRNVM in the left eye, who received 3 injections of intravitreal bevacizumab, with rapid improvement in vision and stability during 11 months follow up. "
01/01/2014 - "The patient had bilateral choroidal neovascularisation secondary to angioid streaks and was treated with intravitreal ranibizumab injections. "
06/01/2011 - "She was diagnosed with subfoveal CNV due to angioid streaks in her right eye and treated with six intravitreal bevacizumab (1.25 mg / 0.05 mL) injections over one year. "
11/01/2010 - "In this large series of angioid streaks-associated CNV, ranibizumab injections allowed stabilization of visual acuity. "
11/01/2010 - "A consecutive series of patients affected with CNV associated with angioid streaks were treated with intravitreal ranibizumab injections (0.5 mg/0.05 mL). "
01/01/2000 - "The outcome of laser treatment for CNV in this case was favorable, because alteration of Bruch's membrane was mild, in the form of angioid streaks."
01/01/1989 - "[Laser treatment of macular subretinal neovascularization in angioid streaks]."
11/01/1988 - "Other investigators are evaluating laser treatment of CNV associated with myopic degeneration, pigment epithelial detachment, and angioid streaks. "
01/01/1987 - "Laser treatment of macular subretinal neovascularizations in angioid streaks."
01/01/1981 - "Laser treatment of choroidal neovascular membranes in angioid streaks."
03/15/1988 - "We treated 30 eyes (24 patients) with angioid streaks and neovascular membranes using light coagulation. "
02/01/1983 - "Prophylactic light coagulation along the angioid streaks to prevent subretinal neovascularisation is not recommended. "
06/01/2003 - "Based on these results, laser photocoagulation is not a good therapy for CNV in angioid streaks."
06/01/2003 - "Eleven eyes of 10 patients with extrafoveal CNV secondary to angioid streaks that underwent direct laser photocoagulation were followed for 5 months or more. "
01/01/1989 - "The authors examined 17 eyes with macular subretinal neovascularization in angioid streaks treated by direct laser photocoagulation. "
02/01/2009 - "The short-term results suggest that intravitreal injection of bevacizumab for the treatment of CNV in patients with angioid streak is well tolerated and highly effective. "
02/01/2009 - "We report the favorable outcome of intravitreal injection of bevacizumab (Avastin) to treat choroidal neovascularisation (CNV) secondary to angioid streaks in an 82-year-old Chinese man. "
10/01/2009 - "To investigate the long-term efficacy of intravitreal injections of bevacizumab (Avastin; Genentech Inc, South San Francisco, California, USA) for choroidal neovascularization (CNV) secondary to angioid streaks. "
01/01/2009 - "To report the efficacy of intravitreal injection of bevacizumab 1.25 mg (IVB) in the treatment of choroidal neovascularization (CNV) secondary to angioid streaks (AS). "
02/01/2009 - "Intravitreal injection of bevacizumab for the treatment of choroidal neovascularization in a patient with angioid streaks."